300194 福安药业
已收盘 11-18 15:00:00
资讯
新帖
简况
股市必读:福安药业(300194)11月16日董秘有最新回复
证券之星 · 11-17 03:43
股市必读:福安药业(300194)11月16日董秘有最新回复
福安药业(300194.SZ)子公司头孢托仑匹酯颗粒纳入国家医保目录
智通财经 · 11-16 15:52
福安药业(300194.SZ)子公司头孢托仑匹酯颗粒纳入国家医保目录
福安药业:公司目前进入注册程序的在申请药品主要为化学仿制药
证券之星 · 11-16 15:06
福安药业:公司目前进入注册程序的在申请药品主要为化学仿制药
福安药业:公司未设置伦理审查委员会机构
证券之星 · 11-10
福安药业:公司未设置伦理审查委员会机构
福安药业(300194)披露子公司收到药品补充申请批准通知书,11月09日股价下跌0.82%
证券之星 · 11-09
福安药业(300194)披露子公司收到药品补充申请批准通知书,11月09日股价下跌0.82%
福安药业最新公告:子公司获注射用拉氧头孢钠药品补充申请批准
证券之星 · 11-09
福安药业最新公告:子公司获注射用拉氧头孢钠药品补充申请批准
股市必读:福安药业(300194)股东户数3.66万户,较上期减少0.9%
证券之星 · 11-09
股市必读:福安药业(300194)股东户数3.66万户,较上期减少0.9%
福安药业:截止最新日期10月30日,公司股东户数为36621户
证券之星 · 11-06
福安药业:截止最新日期10月30日,公司股东户数为36621户
福安药业(300194)11月3日主力资金净买入499.28万元
证券之星 · 11-04
福安药业(300194)11月3日主力资金净买入499.28万元
福安药业:新增部分主要为库存商品
证券之星 · 10-30
福安药业:新增部分主要为库存商品
股市必读:福安药业三季报 - 第三季度单季净利润同比下降46.87%
证券之星 · 10-28
股市必读:福安药业三季报 - 第三季度单季净利润同比下降46.87%
福安药业(300194)披露2026年三季度报告,10月26日股价上涨1.35%
证券之星 · 10-26
福安药业(300194)披露2026年三季度报告,10月26日股价上涨1.35%
福安药业(300194)10月20日股东户数3.7万户,较上期减少2.78%
证券之星 · 10-26
福安药业(300194)10月20日股东户数3.7万户,较上期减少2.78%
福安药业(300194.SZ)发布前三季度业绩,归母净利润1.24亿元,同比下降25.41%
智通财经 · 10-26
福安药业(300194.SZ)发布前三季度业绩,归母净利润1.24亿元,同比下降25.41%
福安药业(300194)披露子公司氟氧头孢钠原料药获批注册公告,10月23日股价上涨1.09%
证券之星 · 10-23
福安药业(300194)披露子公司氟氧头孢钠原料药获批注册公告,10月23日股价上涨1.09%
股市必读:福安药业新发布《关于子公司收到化学原料药上市申请批准通知书的公告》
证券之星 · 10-23
股市必读:福安药业新发布《关于子公司收到化学原料药上市申请批准通知书的公告》
福安药业(300194)10月20日股东户数3.7万户,较上期减少2.78%
证券之星 · 10-22
福安药业(300194)10月20日股东户数3.7万户,较上期减少2.78%
福安药业(300194)10月15日主力资金净卖出301.65万元
证券之星 · 10-16
福安药业(300194)10月15日主力资金净卖出301.65万元
股市必读:福安药业(300194)10月13日董秘有最新回复
证券之星 · 10-14
股市必读:福安药业(300194)10月13日董秘有最新回复
福安药业:公司子公司有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围
证券之星 · 10-13
福安药业:公司子公司有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围
加载更多
公司概况
公司名称:
福安药业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-22
主营业务:
福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是抗生素类、抗肿瘤类、特色专科药类。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号,在行业内具备一定的市场竞争力。
发行价格:
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":3.43,"timestamp":1794985389000,"preClose":3.49,"halted":0,"volume":10064701,"delay":0,"changeRate":-0.0172,"floatShares":968000000,"shares":1190000000,"eps":0.0293,"marketStatus":"已收盘","change":-0.06,"latestTime":"11-18 15:00:00","open":3.5,"high":3.52,"low":3.43,"amount":34786500,"amplitude":0.0258,"askPrice":3.44,"askSize":100,"bidPrice":3.43,"bidSize":1403,"shortable":0,"etf":0,"ttmEps":0.0293,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795051800000},"marketStatusCode":5,"adr":0,"adjPreClose":3.49,"symbolType":"stock","openAndCloseTimeList":[[1794965400000,1794972600000],[1794978000000,1794985200000]],"highLimit":3.84,"lowLimit":3.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":0.94,"roa":"--","peRate":117.064846,"roe":"2.8%","epsLYR":0.06,"committee":-0.0506,"marketValue":4081000000,"turnoverRate":0.0104,"status":1,"floatMarketCap":3321000000},"requestUrl":"/m/hq/s/300194/","defaultTab":"news","newsList":[{"id":"2684642251","title":"股市必读:福安药业(300194)11月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2684642251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684642251?lang=zh_cn&edition=full","pubTime":"2026-11-17 03:43","pubTimestamp":1794858191,"startTime":"0","endTime":"0","summary":"截至2026年11月16日收盘,福安药业报收于3.53元,上涨0.0%,换手率0.8%,成交量7.78万手,成交额2736.61万元。董秘最新回复投资者: 请问300194福安公司有创新药吗?如有,请详细介绍,谢谢董秘: 您好,公司目前进入注册程序的在申请药品主要为化学仿制药,谢谢!当日关注点交易信息汇总:11月16日主力资金净流入20.11万元,占总成交额0.73%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700003594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0028","300194","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683962006","title":"福安药业(300194.SZ)子公司头孢托仑匹酯颗粒纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683962006","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683962006?lang=zh_cn&edition=full","pubTime":"2026-11-16 15:52","pubTimestamp":1794815549,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)发布公告,公司全资子公司福安药业集团庆余堂制药有限公司产品头孢托仑匹酯颗粒被新纳入国家医保目录,支付标准为4.02元(30mg/袋)和5.94元(50mg/袋),支付标准有效期为2027年1月1日至2028年12月31日。头孢托仑匹酯颗粒主要适用于敏感菌引起的浅表性皮肤感染、深部皮肤感染、淋巴管及淋巴结炎、慢性脓皮病等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福安药业(300194.SZ)子公司头孢托仑匹酯颗粒纳入国家医保目录","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0132","300194","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683695808","title":"福安药业:公司目前进入注册程序的在申请药品主要为化学仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2683695808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683695808?lang=zh_cn&edition=full","pubTime":"2026-11-16 15:06","pubTimestamp":1794812782,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)11月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问300194福安公司有创新药吗?如有,请详细介绍,谢谢福安药业回复:您好,公司目前进入注册程序的在申请药品主要为化学仿制药,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600014645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","300194","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682535143","title":"福安药业:公司未设置伦理审查委员会机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2682535143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682535143?lang=zh_cn&edition=full","pubTime":"2026-11-10 08:27","pubTimestamp":1794270467,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!关注到公司主营抗生素类抗感染制剂。请问公司研发活动是否属于《科技伦理审查办法(试行)》规定的审查范围?公司是否已设立科技伦理(审查)委员会?如已设立,其组成结构(隶属层级、成员来源)与委员人数如何?如未设立,主要出于什么原因?临床研究的伦理审查现由内部、合作医院还是外部机构承担?感谢回复!福安药业回复:您好,感谢您的关注,公司目前伦理审查相关部分的工作主要由合作医院承担,公司未设置伦理审查委员会机构,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000010154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","300194","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682381782","title":"福安药业(300194)披露子公司收到药品补充申请批准通知书,11月09日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682381782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682381782?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:42","pubTimestamp":1794235362,"startTime":"0","endTime":"0","summary":"截至2026年11月9日收盘,福安药业报收于3.63元,较前一交易日下跌0.82%,最新总市值为43.19亿元。福安药业全资子公司福安药业集团烟台只楚药业有限公司近日收到国家药品监督管理局签发的药品补充申请批准通知书,批准注射用拉氧头孢钠的上市许可持有人由浙江惠迪森药业有限公司变更为只楚药业,药品批准文号不变。该药品用于敏感菌引起的多种感染症,目前共有12家企业通过或视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900024482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","300194","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682807420","title":"福安药业最新公告:子公司获注射用拉氧头孢钠药品补充申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2682807420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682807420?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:03","pubTimestamp":1794225804,"startTime":"0","endTime":"0","summary":"福安药业(300194.SZ)公告称,公司全资子公司福安药业集团烟台只楚药业有限公司近日收到国家药监局签发的药品补充申请批准通知书,批准注射用拉氧头孢钠(规格0.25g、0.5g、1.0g)上市许可持有人由浙江惠迪森药业变更为只楚药业,药品批准文号不变。该药品用于敏感菌引起的各种感染症,目前共12家(含只楚药业)通过一致性评价或视同通过一致性评价。此次获批将进一步丰富子公司产品线,但生产销售及业绩影响存在不确定性。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900019209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","300194","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682826801","title":"股市必读:福安药业(300194)股东户数3.66万户,较上期减少0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682826801","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682826801?lang=zh_cn&edition=full","pubTime":"2026-11-09 02:56","pubTimestamp":1794164171,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘,福安药业报收于3.66元,下跌1.88%,换手率1.31%,成交量12.66万手,成交额4659.7万元。当日关注点交易信息汇总:11月6日主力资金净流出592.08万元,占总成交额12.71%。股本股东变化:截至2026年10月30日,公司股东户数为3.66万户,较10月20日减少332户,减幅0.9%。谢谢董秘: 您好,截止最新日期10月30日,公司股东户数为36621户,谢谢!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900000831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","300194","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681830137","title":"福安药业:截止最新日期10月30日,公司股东户数为36621户","url":"https://stock-news.laohu8.com/highlight/detail?id=2681830137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681830137?lang=zh_cn&edition=full","pubTime":"2026-11-06 15:27","pubTimestamp":1793950026,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司最新一期的股东户数是多少?谢谢福安药业回复:您好,截止最新日期10月30日,公司股东户数为36621户,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600021292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","BK0239","300194","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680270290","title":"福安药业(300194)11月3日主力资金净买入499.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680270290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680270290?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:42","pubTimestamp":1793756547,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月3日收盘,福安药业报收于3.68元,上涨2.22%,换手率2.07%,成交量20.07万手,成交额7330.32万元。近5日资金流向一览见下表:福安药业融资融券信息显示,融资方面,当日融资买入476.28万元,融资偿还1018.68万元,融资净偿还542.4万元。福安药业主营业务:从事化学药品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400012258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0028","300194","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679262643","title":"福安药业:新增部分主要为库存商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2679262643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679262643?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:30","pubTimestamp":1793345444,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业10月30日在投资者关系平台上答复投资者关心的问题。是否主要为集采中标产品备货,对应订单或约定采购量覆盖情况、预计交付周期如何?是否存在库龄延长或销售低于预期的情况?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000033472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0132","300194","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678883364","title":"股市必读:福安药业三季报 - 第三季度单季净利润同比下降46.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678883364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678883364?lang=zh_cn&edition=full","pubTime":"2026-10-28 03:55","pubTimestamp":1793130908,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘,福安药业报收于3.63元,下跌3.2%,换手率1.77%,成交量17.15万手,成交额6300.67万元。业绩披露要点:2026年第三季度单季度归母净利润2823.64万元,同比下降46.87%;扣非净利润2188.74万元,同比下降50.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800004016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678194350","title":"福安药业(300194)披露2026年三季度报告,10月26日股价上涨1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678194350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678194350?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:37","pubTimestamp":1793025444,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘,福安药业报收于3.75元,较前一交易日上涨1.35%,最新总市值为44.61亿元。该股当日开盘3.68元,最高3.76元,最低3.67元,成交额达4835.58万元,换手率为1.34%。近日,福安药业披露《2026年三季度报告》。报告显示,公司2026年前三季度实现营业收入12.25亿元,同比下降6.90%;归属于上市公司股东的净利润为1.24亿元,同比下降25.41%。扣除非经常性损益后的净利润为1.08亿元,同比下降27.05%。基本每股收益为0.10元,同比下降28.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600037864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0060","BK0028","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678692771","title":"福安药业(300194)10月20日股东户数3.7万户,较上期减少2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678692771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678692771?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:57","pubTimestamp":1793008668,"startTime":"0","endTime":"0","summary":"证券之星消息,近日福安药业披露,截至2026年10月20日公司股东户数为3.7万户,较10月9日减少1057.0户,减幅为2.78%。在化学制药行业个股中,福安药业股东户数高于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年10月9日至2026年10月20日,福安药业区间跌幅为5.21%,在此期间股东户数减少1057.0户,减幅为2.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","300194","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678150521","title":"福安药业(300194.SZ)发布前三季度业绩,归母净利润1.24亿元,同比下降25.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678150521","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678150521?lang=zh_cn&edition=full","pubTime":"2026-10-26 15:52","pubTimestamp":1793001148,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业 发布2026年第三季度报告,公司前三季度实现营业收入12.25亿元,同比下降6.9%;归属于上市公司股东的净利润1.24亿元,同比下降25.41%;归属于上市公司股东的扣除非经常性损益的净利润1.08亿元,同比下降27.05%;基本每股收益0.1元。报告期随着公司前期主要药品制剂集采中标并开始供货,部分品种销量有所提升,制剂收入已呈现稳定,总体营业收入同比基本持平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677154923","title":"福安药业(300194)披露子公司氟氧头孢钠原料药获批注册公告,10月23日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677154923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677154923?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:14","pubTimestamp":1792750499,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,福安药业报收于3.7元,较前一交易日上涨1.09%,最新总市值为44.02亿元。该股当日开盘3.65元,最高3.72元,最低3.54元,成交额达6512.06万元,换手率为1.86%。近日,福安药业(集团)股份有限公司全资子公司福安药业集团重庆博圣制药有限公司收到国家药品监督管理局签发的化学原料药上市申请批准通知书,氟氧头孢钠原料药获批注册,登记号为Y20250000246,包装规格为5kg/听和7kg/听。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300034049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677998319","title":"股市必读:福安药业新发布《关于子公司收到化学原料药上市申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677998319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677998319?lang=zh_cn&edition=full","pubTime":"2026-10-23 01:28","pubTimestamp":1792690131,"startTime":"0","endTime":"0","summary":"公司公告汇总:全资子公司博圣制药收到氟氧头孢钠原料药上市申请批准通知书,登记号Y20250000246,获批规格为5kg/听和7kg/听。股本股东变化股东户数变动截至2026年10月20日公司股东户数为3.7万户,较10月9日减少1057.0户,减幅为2.78%;户均持股数量由3.13万股增至3.22万股,户均持股市值为12.3万元。该原料药属氧头孢烯类抗生素,适用于中重度感染治疗。获批后可在国内上市制剂中使用。董秘: 您好,截止最新日期10月20日,公司股东户数为36953户,谢谢!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300001769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677948956","title":"福安药业(300194)10月20日股东户数3.7万户,较上期减少2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677948956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677948956?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:52","pubTimestamp":1792662764,"startTime":"0","endTime":"0","summary":"证券之星消息,近日福安药业披露,截至2026年10月20日公司股东户数为3.7万户,较10月9日减少1057.0户,减幅为2.78%。在化学制药行业个股中,福安药业股东户数高于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.68万户。从股价来看,2026年10月9日至2026年10月20日,福安药业区间跌幅为5.21%,在此期间股东户数减少1057.0户,减幅为2.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200030777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0028","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675514165","title":"福安药业(300194)10月15日主力资金净卖出301.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675514165","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675514165?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:09","pubTimestamp":1792112968,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月15日收盘,福安药业报收于3.92元,下跌0.51%,换手率1.77%,成交量17.17万手,成交额6765.74万元。近5日资金流向一览见下表:福安药业融资融券信息显示,融资方面,当日融资买入606.79万元,融资偿还855.76万元,融资净偿还248.98万元。福安药业主营业务:从事化学药品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300194","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675364943","title":"股市必读:福安药业(300194)10月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675364943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675364943?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:25","pubTimestamp":1791919511,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘,福安药业报收于3.98元,上涨0.0%,换手率1.71%,成交量16.58万手,成交额6546.68万元。董秘最新回复投资者: 问一下公司有生产治疗鼠疫的药品吗?公司子公司目前有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围,但临床具体使用何种药物治疗需经医生诊断和进行专业的判断,谢谢!当日关注点交易信息汇总:10月13日主力资金净流出128.39万元,占总成交额1.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400003570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675362183","title":"福安药业:公司子公司有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2675362183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675362183?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:12","pubTimestamp":1791875529,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问:问一下公司有生产治疗鼠疫的药品吗?谢谢!福安药业回复:根据国家卫健委发布的《鼠疫诊疗方案(2023年版)》,鼠疫临床分为腺型鼠疫、败血性鼠疫、脑膜炎型鼠疫等多个分型,不同分型治疗方案和用药不尽相同,主要用药有链霉素、四环素、氯霉素、庆大霉素、氟硅诺酮类等药物。公司子公司目前有庆大霉素、左氧氟沙星等药品属于诊疗方案选用或联合用药范围,但临床具体使用何种药物治疗需经医生诊断和进行专业的判断,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300019961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0132","300194","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795027445526,"stockEarnings":[{"period":"1week","weight":-0.0577},{"period":"1month","weight":-0.1044},{"period":"3month","weight":-0.1614},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.2478},{"period":"ytd","weight":-0.2155}],"compareEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":-0.0384},{"period":"3month","weight":-0.0809},{"period":"6month","weight":-0.1277},{"period":"1year","weight":-0.0893},{"period":"ytd","weight":-0.096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36621人(较上一季度减少0.90%)","perCapita":"26441股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":" 福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是抗生素类、抗肿瘤类、特色专科药类。公司多次荣获“中国医药工业百强企业”“中国药品研发综合实力前100强”“中国化药研发实力50强”等荣誉称号,在行业内具备一定的市场竞争力。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}